Clinical Trials Browser

Anemia, Blast Crisis, Breast Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Thrombocytosis, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

NCT04272645 2020-07-15

Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate Cancer

Phase 2 Withdrawn

Genitourinary

Prostatic Neoplasms

Clinical Trials

Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment

Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer

Abemaciclib With or Without Atezolizumab for mCRPC

A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

CLONEVO

UPLIFT

ABEMA Alone or in COMBO With MK-6482

CYCLONE 3

CYCLONE 2

A Study of Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell Carcinoma

CYCLONE 1

MiMe-A

Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate Cancer